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The unbinding process of a protein-ligand complex of major biological interest was
investigated by means of a computational approach at atomistic classical mechanical
level. An energy minimisation-based technique was used to determine the dissocia-
tion paths of the system by probing only a relevant set of generalized coordinates.
The complex problem was reduced to a low-dimensional scanning along a selected
distance between the protein and the ligand. Orientational coordinates of the es-
caping fragment (the ligand) were also assessed in order to further characterise the
unbinding. Solvent effects were accounted for by means of the Poisson–Boltzmann
continuum model. The corresponding dissociation time was derived from the calcu-
lated barrier height, in compliance with the experimentally reported Arrhenius-like
behaviour. The computed results are in good agreement with the available experi-
mental data.
I. INTRODUCTION
Biological processes are driven by interactions between the molecular components of cel-
lular machinery, commonly between proteins and their target molecules (generically termed
ligands). Most of these processes portray a cascade of protein-ligand association/dissociation
events, and thus, knowledge and control of their energetics and kinetics is of key importance
in molecular biology, proteomics, clinical diagnosis, and therapeutic research, to name a few.
Protein-ligand dissociation is, in essence, a fragmentation of complex multi-atomic ag-
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2gregates. Many-body aggregates are very ubiquous in Nature, and have been the object of
extensive experimental and theoretical studies in a wide range of natural science research
fields: examples range from nuclear fission to atomic clusters fragmentation to dissociation
of insulin from its receptor on the cell membrane, etc. A vast amount of data has now
been accumulated, but there is still a need for an efficient and physically sound theoretical
approach that could possibly rationalize these data and make insightful predictions, the
applicability of one such approach being obvious. A first step is to try and identify the
common features underlying dissociation events of different nature.
Clustering and fragmentation processes in nuclear and atomic cluster physics have already
been found to possess many features in common (for a comprehensive review see ref. [1]).
The emerging key idea is that those processes can be successfully described in terms of a
few collective coordinates that define the overall geometry configuration of the escaping and
parent fragments [1, 2]. The same basic concept also holds for similar processes in more
complex systems, like the fragmentation of a dipeptide [3]. On the basis of this principle,
the present paper addresses the dissociation process of an aggregate of higher complexity, a
biological protein-ligand adduct (often referred as a complex).
A most remarkable protein-ligand system is the antibody-antigen one, which is involved
in a fundamental recognition process during the body immune response. This response is
triggered by foreigner molecules – the antigens (antibody generator, AG). One key mecha-
nism whereby the immune system recognizes and targets them for destruction is by releasing
antibodies (anti-foreign body, AB) [4]. ABs are very large proteins, and the human body has
a potential repertoire of 2.5×1011 different ones. Yet, they all feature a basic scaffold: they
consist of two identical “light” (L) and “heavy” (H) chains of amino acids entangled in a
Y-shape fold as shown in Figure 1. Each tip of the Y branches displays a distinctive variable
region, i.e., the specific “lock” for which the target AG has the “key” (see the schematic
inset in Figure 1); the two tips are identical for each AB. The “key” region of the AG can
be a small protein fragment or a hapten. A hapten is a low molecular weight compound
originally attached to some carrier protein, that will also trigger the release of ABs. Upon
exposure to a particular AG, a set of ABs is refined to target it, via a mutation process
[5, 6]. The mutations occur in the referred variable region (hence it is called “variable”).
Along a maturation series, the increase in affinity strongly correlates with an increase in the
corresponding AB-AG dissociation times, τ [4, 7, 8, 9]. Usually, τ is expressed in terms of
3FIG. 1: Overall ribbon representation of a complete AB structure. The two pairs of heavy chains are
depicted in red and blue, and the corresponding light chains in yellow and grey. The dashed ellipse
highlights one of the branches that bind to the antigen (the so called Fab, after fragment binding
antigen), in an all-atom representation; the trapezoidal region puts in evidence the Fab variable
domains (with added hydrogens), and the dashed arc illustrates the chains’ cleavage sections for
these variable domains to be detached. A simplified scheme of AB-AG binding is presented in the
inset.
the rate of spontaneous dissociation, koff = 1/τ .
Not surprisingly, much effort has been devoted to the determination of those koff values,
with some of the most innovative experiments involving sensitive micromanipulation tech-
niques like atomic force microscopy (AFM) and other force probe procedures to measure
AB-AG binding forces [4, 10, 11, 12, 13]. Some further insight into the molecular struc-
ture, interactions and unbinding pathways underlying such single molecule experiments has
4been gained from computer simulations using “force probe” molecular dynamics (FPMD)
[14]. However, the question arises of to what extent the measured unbinding force in the
mechanically speeded up process of pulling out the ligand relates to the thermodynamic or
kinetic parameters describing the spontaneous dissociation. The later arises in the minute
time scale [8] in contrast to the time scales of AFM (millisecond) and FPMD (nanosecond).
There is also the matter of across which pathway is unbinding being forced.
In the absence of a pulling force, one regains the spontaneous (natural) mode of AB-AG
dissociation, a thermally activated barrier-crossing along a preferential path in a multidi-
mensional energy landscape. The contributing activated states (which determine koff) may
well be described in terms of a few collective coordinates, in close analogy to other studied
fragmentation processes [1, 2, 3]. Within this context, it is reasonable to constrain the many
other degrees of freedom that only contribute to the negligible fine structure of the energy
landscape. This is a rational approach to probe the unbinding of a complex biological system
like the AB-AG one, in order to calculate the corresponding energetic barrier and derive koff
from it.
Starting with an experimentally well studied AB-AG complex, an anti-fluorescein one
(vide infra), here we describe a computational approach at molecular (atomistic) level to
explore its preferential unbinding pathways by probing only a few relevant degrees of free-
dom. A detailed analysis of its dissociation pathway and dependence on the distance and
relative orientation of the molecules in question is presented. The introduction of solvent
effects is also discussed along with its implications on the results, and the dissociation rate
(koff) is derived from the calculated energy barriers. Following this introduction, the selec-
tion of the AB-AG system is described in detail. Next, a brief overview of the theoretical
methods adopted in this study is given, in particular the computational level, the force
field and the extent to which the solvent effects have been introduced. In section IV the
results are presented, compared with the available experimental data, and discussed. The
last section is devoted to the conclusions.
II. THE TEST CASE
Fluorescein (Flu) is a synthetic hapten. It is extensively used in fluorescence-based kinetic
measurements of off-rates (koff) [15], and a valuable reference system for the understanding
5of important immunological issues. Anti-fluorescein AB-AG complexes are also clear-cut
models in the sense that Flu is a small inert and rigid ligand (see Figure 2) and the off-rates
of a number of anti-Flu complexes have been found to display an Arrhenius-like behaviour
[7].
The current study has been carried out for the anti-fluorescein IgG monoclonal antibody
4-4-20 (mAb4-4-20), one of the most extensively studied by thermodynamic, kinetic, struc-
tural, spectroscopic, and mutational methods ([16], and references within), and for which
two crystallographic structures of its Fab region (highlighted in Figure 1) have already been
reported [17, 18]. A complete IgG mAb4-4-20 molecule has two identical Fab fragments, each
consisting of two constant and two variable domains. The two variable domains (labelled
VL and VH) constitute the so called Fv fragment (also highlighted in Figure 1), which is
the minimal antigen-binding fragment. In fact, there are many genetically engineered ABs
that feature only the VL and VH domains [19]. This practice further endorses the idea of a
system with a restricted number of binding-determinant degrees of freedom. It also makes
it realistic (and computationally less demanding) to consider just the mAb 4-4-20 variable
domains: VL with 112 amino acids and VH with 118.
III. METHODS
A. Force field
Even reducing the system to the mAb4-4-20 two variable domains plus Flu, it amounts to
ca. 3600 atoms. It is, thus, too big to be computationally addressed at any level of quantum
mechanics. A realistic simplification is to assume that the nuclei move in the average field
created by all particles, and use an empirical fit to this field – an effective potential commonly
known as a force field. One then uses the computationally less demanding classical mechanics
formalism to calculate both static properties (equilibrium structures, relative energies, etc.)
and the time evolution of the system.
Much effort has been devoted to develop force fields suitable for studying proteins, the
CHARMM force field [20] (the one used in the present work) being one of the most widely
6FIG. 2: Structural formula and assigned atom labels for Fluorescein {2-(6- hydroxy-3-oxo-(3H)-
xanthen-9yl) benzoic acid}. The force-field atom types (see sub-section IIIC) and the partial
charges (units of e) are listed in the table underside. The dashed line puts in evidence the two
aromatic (ring) fragments labelled and grouped in the table.
7used nowadays. Its potential energy function reads:
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The energy E is a function of the positions of all atoms in the system. The first four sum-
mations are known as bonding terms: they extend to the topologically defined Nr covalent
bonds ‘r’, Nθ bond angles ‘θ’, Nφ dihedral angles ‘φ’ and Nχ improper torsion angles ‘χ’,
respectively. For some specific bond angles, an additional bonding term may be required as
a function of the distance ‘S’ between the first and third atoms [20]. The term for the bonds
describes the energy required to deform a bond from its equilibrium value (denoted by the
subscript ‘0’), within a harmonic approximation, and an analogous description holds for the
remaining harmonic terms; the dihedral term is chosen differently to satisfy the dihedral
periodicity. The last two summations of equation (3.1) are extended to all N non-bonding
atom pairs ij separated by three or more covalent bonds. The Lennard-Jones 6-12 potential
term accounts for the van der Waals (vdW) interactions: for each atom type (say i), there
is a Ri distance corresponding to a well depth ǫi, with Ri = 2
1/6σi and σi the distance
for which the Lennard-Jones potential equals zero; the Lennard-Jones parameters between
pairs of different atoms are obtained from combination rules, the ǫij values based on the
geometric mean of ǫi and ǫj and Rij values form the arithmetic mean between Ri and Rj.
The Coulombic potential is defined for the pairs of charges qi and qj separated by a distance
rij , and for a given dielectric constant ε (the vacuum one by default). The equilibrium values
in the harmonic terms and the Ri and ǫi values are parameters derived from experimental
data (e.g., crystallographic structures) and ab initio quantum mechanical calculations on
small reference molecules, presented and discussed in ref. [20]. Partial charges (qi, qj) are
8also derived from such ab initio calculations.
B. Implicit solvent
Proteins operate in aqueous solution. Solvation, stability and dissociation of molecules
in water are largely governed by electrostatic interactions. This is particularly pertinent in
proteins: more than 20% of all amino acids in globular proteins are ionized under physiolog-
ical conditions and polar side-chains occur in over another 25% amino acids [21]. However,
introducing explicit water molecules in a computational simulation to account for solvent
effects dramatically increases the calculation time. Moreover, when the calculations involve
any energy minimisation-based technique like calculating minimum energy reaction paths,
the explicit water molecules will arrange in a single conformation matrix, exerting forces on
the solute that are very different from the solvent mean force.
Alternatively, a continuum treatment of the solvent as a uniform dielectric may provide
an accurate enough description of such interactions, as long as one accounts for the fact
that a protein in aqueous solution (the physiological medium) yields a system with two
very different dielectric media [22]. A most physically correct implicit solvent model arises
from solving the so-called Poisson–Boltzmann (PB) equation (see [22, 23], and references
within). The protein (macromolecule) is treated as a low-dielectric cavity bounded by the
molecular surface and containing partial atomic charges – typically taken from the classical
molecular mechanics force field. The solvent (water) is implicitly introduced by assuming a
high-dielectric surrounding of the protein. And since under physiological conditions macro-
molecules are dissolved in dilute saline solutions (water with a dissolved electrolyte), a term
for the average charge density due to the mobile ions is also included. This classical con-
tinuum electrostatics treatment relies on the (reasonable) assumption that it is possible to
replace the ionic potential of mean force with the mean electrostatic potential, neglecting
non-Coulombic interactions (e.g., vdW) and ion correlations. The actual PB equation reads:
∇ · [ε(r)∇ϕ(r)] = −4πρ(r) (3.2)
− 4π
N∑
i=1
eqini(r)λ(r),
with
ni(r) = n
0
i exp(eqiϕ(r)/kBT). (3.3)
9Equation (3.2) relates the electrostatic potential ϕ to the distribution of the protein atomic
partial charges (charge density ρ), the dielectric properties of both the protein and solvent
(ε, position dependent (r)), and the charge density due to the mobile ions given by the
summation term; qi is the charge of ion type i, ni(r) its local concentration, e the elementary
charge and λ(r) a parameter that describes the ions’ accessibility at position r. The boundary
condition is ϕ(∞) = 0. For each ion type, ni(r) is described by a Boltzmann distribution
(3.3) where n0i is the ion’s concentration in bulk solution, kB the Boltzmann constant and T
the absolute temperature. As for the accessibility parameter, a general consensus is that any
point within one ionic radius from the macromolecule is inaccessible (i.e., λ(r) = 0), and it
is implicit that the region inside the macromolecular surface is inaccessible. The remaining
region outside has λ(r) = 1. A typical value for the ionic raidus is the one of Cl− (2 A˚),
considering that Na+Cl− (sodium chloride) is a most frequently chosen electrolyte.
A description of the several possible approximations and numerical techniques used to
solve equation (3.2) is beyond the scope of the present paper, the reader being referred to
the supporting literature of the software used in this work, APBS (Adaptative Poisson–
Boltzmann Solver) [23, 24]. Briefly, the solute’s charges are mapped onto a mesh and the
electrostatic potential in the presence of the dielectric continuum solvent is determined at
each point, via a finite difference numerical solution of the PB equation. The mesh being a
finite one, it is necessary to set up the boundary potentials (at the lattice edge) accordingly.
For the present work, they are approximated by the sum of the Debye–Hu¨ckel potentials of
all the charges, meaning
ϕ =
N∑
i=1
eqi
exp(−ri/λD)
εwaterri
, (3.4)
where λD, the Debye length, reads
λD =
√
εwaterkBT
4πNA
∑N
i=1 n
0
i e
2q2i
. (3.5)
C. Fluorescein parameters
The available CHARMM parameterisation already has parameters for all amino acids but
not for fluorescein, so one has first to describe the later consistently with the force field. In the
present work, the required bonding and Lennard-Jones parameters where derived by analogy
to similar ones existing in CHARMM. Partial atomic charges were fitted to reproduce the
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molecular electrostatic potential (MEP) at selected points around the molecule according to
the Merz–Singh–Kollman scheme [25, 26] implemented in the Gaussian03 program [27]. The
points are located in layers around the molecule, the first layer corresponding to the van der
Waals molecular surface scaled by a factor of 1.4; the default scheme then adds three more
layers with scaling factors 1.6, 1.8 and 2.0. The MEP was generated at the DFT/B3LYP
level with the 6-31G(d) basis set. DFT (density functional theory) is now a widely used
and computationally convenient quantum mechanical method well documented in many
reference books (e.g., [28]): it makes use of exchange correlation functionals dependent on
the electron density and its gradient to tackle electron correlation effects. B3LYP was the
functional of choice and stands for the three-parameter Becke functional combined with the
Lee-Yang-Parr correlation functional [28].
For the quantum mechanical calculations, the coordinates for the starting Flu conforma-
tion were taken from the complex crystal structure with the best resolution (1.85 A˚ [18]),
which has the coordinates deposited in the RCSB Protein Data Bank [29] with entry name
1FLR. Only the acidic deprotonated form of Flu was considered, since this is the active form
in the experiments underlying the current study. The structure was energy optimized before
charge fitting. The charges were then further refined by similarity to the set of already
defined ones in the CHARMM force field (for details on the approach see [30, 31, 32]). The
ensuing Flu set of parameters was then used as an extension of the CHARMM parame-
terisation, the corresponding CHARMM atom types and partial charges being indicated in
Figure 2.
D. Reference geometry
The variable domains (VL and VH) were extracted from the L and H segments of the anti-
Flu 4-4-20Fab 1FLR crystal structure [18, 29]. Crystallographic waters were stripped from
the structure and the C-terminal amino acids were capped with –NH2 functional groups. A
representation of the system is shown in Figure 3. The positions of the protein’s missing
hydrogens were initially guessed. Next, any latent close contacts or anomalous bonding
positions were cleared out by relaxing the structure to an energy gradient tolerance of 0.05
eV·A˚−1, at the classical mechanics level using the NAMD program [33] with the extended
CHARMM parameterisation. This relaxed structure fully retains the experimental X-ray
11
conformational features and it was used as the starting conformation for the scanning. A
full structure optimisation (i.e., using a tighter energy gradient tolerance) was also carried
out but it introduced many small errors at the protein’s secondary structure level. This
is because secondary structure relies on a network of backbone hydrogen bonds, which are
less accurately described in the framework of the simplified molecular mechanics force field
theories. The CHARMM energy difference between the relaxed and fully minimised geome-
tries is ∼100 eV. The crystallographic structure itself has been resolved at a temperature of
∼290 K [18], thus an estimate of the corresponding average thermal energy (considering kBT
per degree of freedom) amounts to ∼270 eV for our simulation system. This indicates that
the full minimisation is only reaching some local minima. Considering the above referred
limitations of the force field, it is judicious to take the minimally relaxed structure (closer
to the X-ray one) as the reference structure for the subsequent simulations.
Flu is a particularly rigid molecule. Its essential degree of freedom is the torsion around
the bond between the xanthenone and the carboxyphenyl aromatic rings (see Figure 2),
defining the angle between the planes of these two rings. This angle has the value of −63◦
in both the crystal complexed form [18] and the crystalline free Flu [34]. For the above
referred CHARMM energy relaxed structure, the value of this angle is −67◦. An energy
optimization was also carried out for the hapten alone (without the AB), the value for the
angle in question being -62◦. Moreover, the RMSD (root-mean-square deviation) between
the crystallographic and relaxed Flu bound structures is 0.201 A˚. These results are a good
indication of the validity of the derived set of CHARMM parameters.
E. Distance scanning
In the pursuit for the suitable reaction coordinates to describe the system’s unbinding, the
distance between the protein and Flu mass-centres could be a first option, in close analogy
to some cluster fission processes [1]. Yet for reasons that will become clear next, a distance
between two rationally selected atoms has been considered instead.
The shape of the binding pocket hosting Flu is most complementary to this hapten,
with a few amino acids at the rim of the pocket gating the entrance. Superimposing
the two available crystal structures results in an overall RMSD of 0.419 A˚ for the Flu
atoms and 1.854 A˚ for the protein, with a few of those rim amino acids exhibiting some
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FIG. 3: All-atom representation of the Fv-fragment of the mAb4-4-20-Flu complex structure. The
ribbon representation highlights the backbone of the two chains, the H-chain in blue and the
L-chain in gray. The Flu molecule is depicted in ball-and-stick and coloured by element (CPK
space-filling).
of the larger individual RMSD values (up to 3.7 A˚). Out of those, five amino acids –
His31L, Asn33L, Tyr56H , Tyr102H and Tyr103H – strategically “frame” amino acid Arg39L
at the bottom of the pocket, as depicted in Figure 4. Amino acids are labelled (in
the text and Figure 4) according to the standard amino acid 3-letter code ([5]; see also
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FIG. 4: Fluorescein (van der Waals spheres in shades of grey) docked in the antibody’s binding
cavity. The backbone of the antibody is depicted in black sticks; the framing amino acid acids
(labelled as described in the text) have their side-chains displayed in coloured ball-and-stick. (A)
front view of the entrance of the cavity. (B) top view showing residue Arg39L at the bottom of
the cavity, with its atom Cζ (zeta-carbon, standard nomenclature) highlighted in yellow: the red
dotted lines represent hydrogen bonding between Arg39L and the hapten.
http://www.chem.qmul.ac.uk/iupac/ AminoAcid/), the number of the amino acid in the
1FLR file and the chain identifier in subscript (e.g., Arg39L, refers to an Arginine that is
numbered 39 in the L-chain). As highlighted in Figure 4-B, Arg39L has its +1-ionized group
(centred on atom Cζ) directly involved in hydrogen bonding to the hydroxyl group of Flu
(atoms O1–H12 in Figure 2). Arg39L is also a mutation introduced during the matura-
tion process of mAb4-4-20 [9]: the original residue was a neutral, weakly polar Histidine.
Upon this His-to-Arg mutation a slowing in the unbinding of Flu by a 1.5-fold was exper-
imentally observed [9], no doubt in consequence of the increased attraction between the
mutated amino acid 39L and Flu. Thus, it was only logical to consider the distance between
the groups of Arg39L and Flu engaged in that driving hydrogen bonding as a most likely
14
unbinding coordinate.
The distance between the Cζ atom of Arg39L and the Flu’s hydroxyl oxygen (O1) was
then set as the appropriate coordinate for scanning. The scanning started from the distance
in the reference conformation and progressed in increments of 0.25 A˚ until a ∼40 A˚ distance.
At this distance and for the set cut-off, the interaction energy between the hapten and the AB
becomes zero. The scanning was also performed for a few decreasing steps, i.e., for distances
smaller than the one in the reference structure. The distance value at each scanning step was
imposed by means of a strong harmonic constraint (force constant = 26 eV·A˚−2) between
the referred oxygen and a dummy atom placed at the same coordinates of the Cζ atom. The
need for a dummy atom arises from the fact that, in CHARMM, the non-bonding energy of
all atom pairs separated by less than three covalent bonds is excluded [20]; the introduced
harmonic constraint is an “artificial bond” and therefore should not be directly set between
the Cζ and OH atoms, otherwise several pair interactions between Arg39L and Flu would
be wrongly excluded.
For each scanning step, the system was energy minimised with NAMD to an energy
gradient tolerance ≤ 4×10−4 eV·A˚−1. A 12 A˚ cut-off on long-range interactions with a
switch smoothing function between 10 and 12 A˚ was used. During minimisation, the hapten
was free to move (subject only to the scanning harmonic constraint) while the AB was kept
frozen for all but the side-chain atoms of a few key amino acids gating the passage of the
hapten. The unconstrained side-chains belong to His31L, Asn33L, Arg52H, Tyr56H , Glu59H,
Tyr102H and Tyr103H . The reported energy of each minimised structure was calculated after
removing the referred harmonic constraint. In NAMD, it is not possible to set two different
dielectrics within the same system, so minimisations were performed for ε = 1, and solvent
effects were introduced as corrections a posteriori, as described next.
For the final conformation of each scanning step, the electrostatic energy was recalculated
using the APBS program (refer to sub-section IIIB). The conformation of the last scanning
step roughly occupies a 70 A˚-side cubic box. The side was extended by an extra 20 A˚ for
solvent media, resulting in a 90×90×90 A˚3 box that was set equal for all scanning steps.
Calculations were performed using the APBS’ adaptive refinement [35]. A low dielectric
constant of ǫ = 2 was set for the macromolecule cavity [22, 36] and the typical water value
of ǫ ≈ 80 was set for the continuum solvent medium. The effect of a dilute electrolyte in
solution was assessed with a second run of calculations, for a salt bulk concentration of 0.150
15
mol·dm−3 as in a typical physiological media [25], and a temperature of 298 K.
F. Exploring relative orientations
The distance scanning scheme above described does not enforce an escaping channel
along a straight line, nor does it restrain the AB-hapten relative orientations. For the sake
of completion, a comprehensive overlook of the two molecules relative position and mutual
orientation should be performed. The designated appropriate descriptors are the spherical
coordinates (r, θ, φ) and three Euler angles (α, β, γ), for which two coordinate frames
are required. The referential frame, set as the protein’s principal axes of moment of inertia
given that the protein is fixed in space, and the moving-body local frame, i.e. the Flu frame.
Care was taken to select this later, considering that during the scanning Flu does not evolve
in space as a completely rigid body. Its centre was set in Flu’s atom C1 since along the
scanning the position of Flu’s mass centre is approximately coincident to this atom (0.2-0.4
A˚ RMSD). The xy plane was made coincident to the rigid xanthenone ring, with the x axis
pointing in the direction of atom O1, as displayed in Figure 5.
FIG. 5: System of internal axes for Flu.
16
G. Calculation of koff
In compliance with the experimentally reported Arrhenius-like behaviour [7] and within
the context of the reaction-rate theory [37], the off-rate constant along the scanned pathway
was computed using the expression,
koff = ω exp(−∆E
‡/kBT) (3.6)
where ω is the pre-exponential factor determining how frequently the system approaches
the barrier, and ∆E‡ is the activation energy (i.e., the barrier height). The harmonic
approximation was used to estimate the Arrhenius-like pre-factor. It reads
ω =
1
2π
√
k/µ, (3.7)
where µ is the reduced mass of the system and k the harmonic force constant. This latter was
obtained from parabolic fit of the data (the bounding region of the well in the energy profiles)
using the Mathematica R© software package. For systems similar to the one presented here
(with reduced masses in the 200-500 range and binding pocket’s length within 3-7 A˚), an
estimation of the frequency ω falls in the 1011-1012 s−1 range.
IV. RESULTS AND DISCUSSION
A. Energetic and structural analysis
The energy profiles resulting from the scanning runs with and without solvent correction
are plotted in Figures 6 and 7.
Figure 6 displays the in vacuo results for four different scanning runs, corresponding to
different constraining schemes on the protein atoms. The scheme referring to the seven
unconstrained side-chains enumerated in sub-section III E has been labelled ‘c1’ in Figure 6.
To better assess on the influence of those 7 amino acids on the escaping profile, they were
subject to successive constraining procedures, exemplified in Figure 6 for three representative
cases, labelled ‘c2’, ‘c3’ and ‘c4’, that correspond to six, five and four unconstrained side
chains (out of the initial seven). The plotted ‘c3’ curve, for instance, results from moving
only the side-chains of the 5 gating residues sginaled out in the second paragraph of sub-
section III E and visible in Figure 4-B.
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FIG. 6: Energy profiles (in vacuo) for different distance scanning runs, corresponding to different
constraining schemes on the protein atoms. Each curve corresponds to a different number of gating
amino acid side-chains that were allowed to move during each scanning, namely seven side chains
(c1), six (c2) five (c3) and four (c4) (details in the text).
The constraining limit is the set of amino acids Asn33L, Tyr56H , Tyr102H and Tyr103H
corresponding to the ‘c4’ curve. Within this limit, no general significant differences on
the energy profile arise from the explored different schemes. These 4 amino acids always
experience significant conformational changes upon the hapten’s passage, in comparison to
the remaining moving ones which just slightly adjust positioning. The plane defined by the
side-chain oxygens of the 4 amino acids in question can be taken as the outmost limit of the
protein’s pocket, and it is intersected at a ∼15 A˚ scanning distance. Below this separation
distance, the total energy plots in Figure 6 depict the expected profile for an activated
process. For the different curves, the height and shape of the energetic barrier at ∼7 A˚ is
essentially the same: 1.029, 1.027, 1.060 and 1.026 eV respectively for 7, 6, 5 and 4 moving
side-chains. Past the 15 A˚ distance, the in vacuo profiles depict an asymptotic increase to a
final plateau above the referred energetic barrier, making unbinding unfeasible. Predictably,
the inclusion of solvent effects rectify the asymptotic behaviour depicted in the in vacuo
profiles, as exemplified in Figure 7 for two scanning runs. At larger separation distances
the energy profile has been significantly flattened, ant it is also for the larger distances that
18
FIG. 7: Comparison of the distance scanning energy profiles in vacuo and with implicit solvent
corrections (with and without dissolved electrolyte), for the ‘c2’ and ‘c3’ constraining schemes.
the effect of the dissolved electrolyte becomes perceptible. In solution, the electrostatic
interactions between the protein and the escaping hapten are effectively screened by the
high-dielectric, allowing for unbinding to happen. Of relevance is also the decrease in the
height of the energetic barrier at ∼7 A˚: with implicit solvent effects, this barrier value is
0.863 and 0.871 eV, respectively for the ‘c2’ and ‘c3’ schemes.
The jagged contour emerging at ∼20 A˚ also deserves some attention. A detailed analysis
19
FIG. 8: Electrostatic energy profiles (in vacuo) for the overall system, its intermolecular component
and the interaction energy between the protein and the COO− group (atoms C20, O4, O5 of the
Flu’s carboxyphenyl ring; see Figure 2). The picture on top portraits the path of that ring along
the scanning: the dashed yellow straight line puts in evidence the coordinate being scanned while
the circle emphasises the anchor point of the COO− group at the protein’ surface (see details in
the text). The grey area puts in evidence a jagged region in the profile.
of the energetic components was carried out, with particular emphasis on the Coulombic
component, as exemplified in Figure 8 for scanning run ‘c2’. A previous work had already
shown that, at larger distances, electrostatics play a major role in fragmentation [3]. By
comparing Figures 7 and 8, one perceives the jagged pattern similarities between the total
energy and its electrostatic component. Moreover, the electrostatic energy and its inter-
molecular component – i.e., the electrostatic interaction energy between the protein and the
hapten – run parallel. To this intermolecular energy, a major contribution comes from the
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COO− group of Flu. This group gets anchored via hydrogen-bonds at the protein’s surface
as the hapten leaves the pocket: the anchor point is yellow circled in the top picture of Fig-
ure 8. The hapten rotates around this point as the scanning distance is further increased,
until it finally detaches from the surface. The detachment features a somewhat irregular
trajectory of the escaping hapten: it is the region of the top picture in Figure 8, right above
the grey area highlighting the jagged contour in the plot. A better perception of the hapten’s
rotation as it leaves the binding pocket can be gained from the plotting of the Euler angles
along the scanning, presented in Figure 9. The steeper variation of the angles in the 15-20
A˚ region corresponds to the anchoring track of the COO− group at the protein’ surface. As
the hapten detaches, a swift change in its orientation is observed, made evident by the plots
for the Euler angles from ∼20 A˚ on. At this stage, one can not ascertain whether or not
this pronounced “trapping” of the hapten to the protein’ surface is a genuine feature of the
unbinding. That would at least require the other known mutations of the anti-fluorescein
mAb4-4-20 to be subject to an analogous study, which is beyond the scope of the present
paper.
The fact remains that, on the overall, the total energy profiles are smooth (without
discontinuities), as clear from the top plot in Figure 10 of the energy as a function of both
the scanning coordinate and the radial distance (r). They portray a plausible unbinding
channel, provided solvent effects are included, though one can not claim that they correspond
to the minimum energy pathway. One possible step to assess that would be to perform a
more comprehensive probing of the positional/orientational space of the hapten – beyond the
points determined by the presently selected reaction coordinate. Yet, such a study involves
a substantial computational effort, even if confined to some plausible escaping window in
space. On the other hand, the presently computed profiles can be used to derive koff , and by
comparison to the corresponding experimental values(s), a first evaluation of the scanning
approach here introduced can be made.
B. koff determination
Table I presents the calculated values of koff , with and without solvent correction, re-
sulting from parabolic fit to the profiles (0.99 ≤ R2 ≥ 0.87), considering the energy barrier
at ∼7 A˚ (vide supra). Experimentally available koff values are also presented for compari-
21
FIG. 9: Euler angles as a function of the scanned distance coordinate.
son. It becomes immediately evident that, even for an extensively studied system like the
mAb4-4-20–fluorescein one, experimental koff values may differ by an order of magnitude,
depending on setup conditions and techniques [9, 38, 39]. As for our estimated values, while
the in vacuo results are off-range, the solvent-corrected ones are comparable to the exper-
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FIG. 10: Spherical coordinates along the ‘c2’ scanning run. The total energy of the system is
plotted as a function of both the radial distance (r) and the scanned distance coordinate. The
angles θ and φ are plotted only as a function of the scanning distance coordinate.
imental results. The equilibrium distance between the antibody and the hapten (the well
minimum) also compares better to the experimental value in the case of the solvent-corrected
simulations. Finally, remark that the different constraining schemes have little influence on
the order of magnitude of the koff values.
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TABLE I: Kinetic and equilibrium parameters obtained from calculations based on the compu-
tational scanning. Available experimental values are also presented for comparison: (a) and (c)
determined in solution (ref. [38] and [39] respectively), and (b) at a surface by SPR [9].
parameter
simulations
experimental T(K)
in vacuo solvent corrected
c2 c3 c2 c3
1.9 × 10−3 (a) 291
koff(s
−1) 3.4× 10−6 6.8 × 10−6 4.1 × 10−3 5.4× 10−3 6.8× 10−3 (b) 298
4.3× 10−3 – 2.5 × 10−2 (c) 298
equilibrium
3.50 3.55 3.60 3.65 3.65 291
distance (A˚)
V. CONCLUDING REMARKS
Here we presented our first attempt to describe the unbinding of a complex biomolecular
system in terms of a reduced set of relevant generalized coordinates while restricting most
of its conformational internal degrees of freedom. The reported results open a practical
and physically sound procedure to compute energy profiles along the selected reaction co-
ordinate(s). This was demonstrated in the present work for an experimentally well studied
complex of the biologically relevant antigen-antibody system. For the example in question, it
was actually possible to find a distance dependent escaping channel in the multidimensional
potential energy landscape, thus reducing the unbinding to a low-dimensional problem: the
system seems to be efficiently bound by this one distance coordinate. The effect of the
solvent was also accounted for, and despite the fact that it was introduced as a correction a
posteriori, it allowed us to ascertain that this is one effect that needs to be included, for it
has a significant influence in the overall energetic profile and subsequent parameters derived
from it. With solvent effects, the derived off-rates are in reasonable agreement with the
experimentally determined ones, a result that can be regarded as an indicator that ours is
indeed a realistic approach.
The proposed approach would no doubt benefit from further refinements, namely in the
way solvent effects are introduced (viz. include them during scanning, both implicit and
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explicitly) and in the kinetic model, which we intend to carry on in the near future. We
also have in mind to apply this same approach to the maturation series and engineered
mutants of the 4-4-20–fluorescein complex. That would allow us to further test our strategy,
in particular its sensitiveness to the energetic differences arising from antibody’s single-point
mutations. In addition, computed association rates would be valuable parameters in different
areas of immunological research, namely theoretical immunology [40]. Remark also that
calculated koff values could be used to determine the related association rate kon using the
relation kon = koff/Kd[9], for those systems where only the equilibrium dissociation constant
Kd has been experimentally measured. And by identifying and rationalize the involved key
structural features and interactions determining the unbinding, one could make insightful
predictions and propose, for instance, affinity-enhancing mutations. Our long term goal is
to extend our research to other molecular recognition processes besides the antigen-antibody
one and to test the applicability and universality of our approach.
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